Tops & Flops Stocks
| Security | Change (%) | 1w | 1m | 1y ▲ | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Fibrogen Inc. | -13.080% | 34.144% | -15.400% | -91.968% | 47.558% | -92.369% | - |
| Novocure Ltd | 1.490% | 25.795% | 13.841% | -76.180% | 1.121% | -90.875% | - |
| Bluebird Bio Inc. | -5.190% | 12.437% | -16.515% | -76.124% | -24.284% | -96.229% | - |
| Sage Therapeutics Inc. | 0.040% | -7.586% | -20.370% | -70.585% | -39.700% | -79.833% | - |
| Emergent Biosolutions Inc. | 9.620% | 132.380% | 95.476% | -47.101% | 84.246% | -91.900% | -90.646% |
| PTC Therapeutics Inc. | -0.660% | 1.342% | 20.800% | -39.600% | 19.841% | -9.036% | -5.743% |
| Arrowhead Pharmaceuticals Inc. | -1.030% | 9.571% | -2.353% | -38.093% | -17.472% | -57.420% | 43.865% |
| Alnylam Pharmace. | 0.280% | 6.377% | 1.199% | -25.442% | -18.955% | 30.706% | 117.678% |
| Ironwood Pharmaceuticals | 0.680% | 2.069% | -1.333% | -23.711% | -27.451% | -18.681% | - |
| Acadia Pharmaceuticals | 0.380% | 1.153% | -4.964% | -20.628% | -44.384% | -8.831% | -32.457% |
| Xencor Inc. | -0.890% | 20.856% | 14.141% | -8.871% | 9.709% | -35.244% | - |
| Opko Health Inc. | -7.520% | 5.305% | -2.952% | -8.032% | -14.189% | -60.895% | -41.771% |
| Ultragenyx Pharmaceutical Inc. | -2.010% | -2.913% | -13.793% | -6.542% | -8.257% | -52.941% | -33.753% |
| Ligand Pharmaceuticals | 8.760% | 2.256% | -5.556% | -6.207% | 4.615% | -35.207% | -38.462% |
| Repligen Corp. | -0.100% | 0.678% | -2.225% | 9.244% | -6.921% | 1.102% | - |
| Exelixis Inc. | -0.390% | -7.458% | -4.728% | 15.037% | -6.993% | -1.405% | 12.555% |
| Ionis Pharmaceuticals Inc. | -1.290% | -1.475% | -4.585% | 21.120% | -16.619% | 26.764% | -37.141% |
| Catalent Inc. | 0.340% | 0.459% | 0.401% | 21.246% | 27.573% | -40.610% | 26.957% |
| Charles River Labs Intl | -0.090% | 1.524% | -5.948% | 26.649% | 3.192% | -22.057% | - |
| United Therapeutics | 2.440% | 12.608% | 14.590% | 27.263% | 24.792% | 49.036% | 179.769% |
| Agios Pharmaceuticals Inc. | -3.110% | 1.307% | 21.094% | 33.621% | 50.485% | -32.211% | -30.657% |
| Halozyme Therapeutics Inc. | 5.450% | 4.955% | 1.161% | 36.393% | 13.264% | -1.969% | - |
| Neurocrine Bioscience | -1.430% | 3.260% | 3.702% | 50.509% | 11.526% | 77.684% | 86.188% |
| Blueprint Medicines Corp | -0.990% | 17.936% | 19.357% | 88.785% | 22.424% | 30.694% | - |
| Nektar Therapeutics | 9.510% | 2.566% | 14.391% | 93.714% | 180.867% | -91.537% | - |